Vanguard Investments Australia
RYTM icon

Vanguard Investments Australia’s Rhythm Pharmaceuticals RYTM Stock Holding History

Vanguard Investments Australia’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Buy
14,666
+739
+5% +$66.8K ﹤0.01% 1017
2026
Q1 		$1.21M Buy
+13,927
New +$1.35M ﹤0.01% 1088

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Investments Australia's RYTM Position: Q2 2026 in Review

Vanguard Investments Australia increased its Rhythm Pharmaceuticals (RYTM) stake by 5.3% in Q2 2026, buying an estimated $66.8K and bringing the position to 14,666 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1017.

Vanguard Investments Australia first reported a position in RYTM in Q1 2026 and has held it in 2 quarters since. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Vanguard Investments Australia held 14,666 shares of Rhythm Pharmaceuticals worth $1.63M as of Q2 2026.
  • Vanguard Investments Australia bought 739 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $66.8K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1017 holding.
  • Vanguard Investments Australia first reported a position in Rhythm Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.